Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.

Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.

Item
http://www.wikidata.org/entity/Q48502465
Retrospective analysis of the efficacy of omalizumab in chronic refractory urticariaThe pathologic and clinical intersection of atopic and autoimmune disease.Anti-IgE--emerging opportunities for Omalizumab.The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria.Successful treatment of refractory idiopathic angio-oedema with omalizumab: review of the literature and function of IgE in angio-oedema.Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature.Novel Biologicals for the Treatment of Allergic Diseases and Asthma.Efficacy of Treatment of Non-hereditary Angioedema.Omalizumab in recurring larynx angioedema: a case report.Treatment of Chronic Spontaneous Urticaria with a Single Dose of Omalizumab: A Study of Four Cases.Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.Global Burden of Urticaria: Insights from the 2016 Global Burden of Disease Study.A patient with steroids and antihistaminic drug allergy and newly occurred chronic urticaria angioedema: what about omalizumab?Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.
P2860

Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.

Item
http://www.wikidata.org/entity/Q48502465
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Omalizumab markedly improves u ...... patients: a real life survey.
@en
Omalizumab markedly improves u ...... patients: a real life survey.
@nl
type
label
Omalizumab markedly improves u ...... patients: a real life survey.
@en
Omalizumab markedly improves u ...... patients: a real life survey.
@nl
prefLabel
Omalizumab markedly improves u ...... patients: a real life survey.
@en
Omalizumab markedly improves u ...... patients: a real life survey.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Omalizumab markedly improves u ...... patients: a real life survey.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1346-8138.2011.01473.X
P433
P478
P50
P577
P5875
P698
P921